Drawing for JRH

USPTO serial 75264521

JRH

Reviewed by CopyMark Law Group

Reg. 2194937Status 710
Filing date
Status date
Registration date
Oct 13, 1998
Examiner
MANDIR, FREDERICK
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with JRH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

DONALD S. GARDNER

DONALD S GARDNER VAN DYKE GARDNER LINN & BURKHART LLP2851 CHARLEVOIX DR SE STE 207PO BOX 888695GRAND RAPIDS, MI 49546

Goods and services

ClassDescriptionStatusFirst use
001chemical, biochemical and biological preparations, and reagents and test kits primarily comprising such preparations and reagents all for medical research, scientific or industrial use; cell media and sera for use in the production of pharmaceuticals, vaccines, monoclonal antibodies and recombinant proteins; sera alternatives, namely, biochemical/protein mixtures to replace or eliminate the need for sera products in cell culture applicationsSECTION 8 - CANCELLEDApr 18, 1990
005chemical, biochemical, and biological preparations, reagents and test kits primarily comprising such preparations and reagents all for medical or clinical use; cell cultures and media for medical or clinical use; antibodies for use in the treatment of infectious diseases; and naturally derived animal blood products, namely, serums for medical or clinical use; chemically defined media and media supplements for the growth of bacterial, viral or animal cells in cultureSECTION 8 - CANCELLEDApr 18, 1990

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 16, 2009CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Sep 12, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 18, 2005C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
May 16, 2005PLGLASSIGNED TO PARALEGAL—
Apr 13, 2005815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Apr 13, 2005E815TEAS SECTION 8 & 15 RECEIVED—
Oct 13, 1998R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 1998NPUBNOTICE OF PUBLICATION—
Apr 16, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 13, 1998CNEAEXAMINER'S AMENDMENT MAILED—
Mar 16, 1998CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 14, 1997CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 1997DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance